Skip to main content
AKTS logo

AKTS · Aktis Oncology, Inc. · Holdings

Track AKTS — free
$15.73 -1.03 (-6.15%) At close · Oct 23
Market Cap
$874.89M
Shares
55.62M
Volume · Oct 23 241.76K Avg daily vol (3M) 364.06K

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Recent SEC filings are still being reconciled. Holder totals and changes may be incomplete until processing catches up.
The Sep 30, 2026 filing window is still open — showing the latest known positions. Funds that have not filed yet carry their prior-quarter positions; a fund that filed without this stock counts as sold out. Each fund's Change is measured against its own previous reported quarter, shown in the Reported column. Pick a completed quarter in the Quarter selector below to put every fund on one quarter and see the stock-wide activity breakdown.
Holders: 115
Total Value: $1,102,905,451
Total Shares: 34,279,824
Showing 1–100 of 115 holdings by value · page 1 of 2

Institutional Ownership Trend

3 quarters

Holder Concentration

Across 113 13F filers
Top Holder
14.2%
Mar 2026 → Jun 2026 · range 13.9% – 14.2%
of institutional value
Top 5
49.9%
Mar 2026 → Jun 2026 · range 49.7% – 49.9%
of institutional value
Top 10
71.0%
Mar 2026 → Jun 2026 · range 71.0% – 73.4%
of institutional value
HHI
698
Mar 2026 → Jun 2026 · range 698 – 710
Broadly held

Who Holds AKTS

Last 3 quarters through Sep 30, 2026 (filing window open)

Each kind of 13F filer's share of the common shares 13F filers report. Holder type comes from regulatory records, never the filer's name; style, turnover and horizon are measured from each filer's own 13F book. The quarter selector does not change this card.

Jun 30, 2026, the newest closed quarter: 113 filers, like-for-like change -1.6%; actively managed books -2.8%; index-like books +7.5%.

Holder type Share Filers Change
Registered adviser 43.5% 58 -5.0%
Adviser 29.2% 5 -2.4%
Bank 3.2% 13 +1.7%
Benefit plan 0.0% 2 -5.9%
Non-US 0.2% 4 +15.5%
Holding company 13.6% 6 -5.0%
Unknown 10.3% 25 +24.6%

The Sep 30, 2026 filing window is still open, so its bar carries the Jun 30, 2026 positions of filers that have not filed yet.

How the mix is measured

Shares are 13F common shares restated to today's split basis; options and principal amounts are left out. The change compares only filers with a 13F in both quarters and keeps each filer in its bucket of the later quarter on both sides; a filer that continues under a new CIK is compared through its successor. Holder type comes from each filer's current regulatory profile; client base and private funds come from the Form ADV roster current at each quarter end (rosters from December 2019, so an earlier quarter reads Unknown). Style, turnover, horizon and book size are measured from each filer's 13F book in the newest measured quarter, and Not measured means none was. Actively managed books are those measured systematic-like, concentrated or diversified active.

Excluded 1 holder with no observed 2026-03-31 13F and 1 holder with no observed 2026-06-30 13F. Compared across CIK changes: JANUS HENDERSON GROUP PLC continues as Jupiter Topco LLC.

Conviction and Crowding

113 13F filers, quarter ended Jun 30, 2026

Measured across every 13F filer's common-share book once the quarter's filing window closed. Crowding counts filers with high turnover or that advise private funds on Form ADV.

Conviction holders
5
4.42% of filers hold it in their top 10
Mar 31, 2026: 4
Holders above 5%
4
median weight 0.001%
Mar 31, 2026: 3
Crowding
—
the issuer has more than one class of common stock, so its count is the total across classes
Private-fund advisers
—
of shares outstanding
Institutional ownership
—
the issuer has more than one class of common stock, so its count is the total across classes
Top 10 holders
71.0%
of 13F shares, Herfindahl 0.070
Active holders
-2.8%
like-for-like share change of active filers
5% stakes on record
3
2 13D, 1 13G (1 institutional, 0 passive, 0 exempt)
How long holders have held it value-weighted 1.9 quarters
Under 1 year 100.0% 1 to 3 years 0.000% 3 years or more 0.000% Since coverage start 0.000%

Managers in the top fifth by current three-year FundScore alpha were net buyers of $0 (0 buying, 0 selling).

Estimated Holder Cost Basis

Quarter ended Jun 30, 2026, on that quarter's share basis

Estimated, never filed: each 13F buy is costed at its quarter's average traded price and each sale keeps the average cost, so this is what holders paid on average if they traded evenly through each quarter.

Estimated avg cost
$19.48
estimated per share
Mar 31, 2026: $19.42
Quarter-end price
$32.23
implied by 13F values
Estimated gain or loss
+65.4%
price against the estimated cost
Estimated at a loss
0.000%
of costed 13F value

Estimated cost covers 96.8% of the 13F shares; positions already held when a filer's 13F history starts, or bought in a quarter without a trusted average price, have no estimate.

Shared Holders

Companies AKTS's active holders also own, quarter ended Jun 30, 2026
# Company Shared holders
1 CNTX Context Therapeutics Inc. 5
2 TRDA Entrada Therapeutics, Inc. 4
3 EVMN Evommune, Inc. 5
4 EIKN Eikon Therapeutics, Inc. 4
5 XNCR Xencor Inc 4
6 IRON Disc Medicine, Inc. 6
7 BIOA BioAge Labs, Inc. 5
8 TYRA Tyra Biosciences, Inc. 4
9 JBIO Jade Biosciences, Inc. 4
10 TSHA Taysha Gene Therapies, Inc. 5

Shareholder Targets

13F filers that own its peers but not AKTS, quarter ended Jun 30, 2026

Found through its holder-overlap peers: CNTX, TRDA, EVMN, EIKN, XNCR, IRON, BIOA, TYRA, JBIO, TSHA, IMA, NGNE, DNTH, CGEM, STOK, WVE, ZLAB, IMTX, DBVT, TRAX. 566 filers in all.

# Filer In peers
1 BVF INC/IL Unknown, Concentrated $441,002,786 6 held
2 Fairmount Funds Management LLC Registered adviser, Concentrated $348,504,014 2 held
3 Vestal Point Capital, LP Registered adviser, Diversified active $341,807,460 5 held
4 Lynx1 Capital Management LP Registered adviser, Concentrated $297,204,756 5 held
5 Siren, L.L.C. Unknown, Diversified active $285,416,836 6 held
6 DEERFIELD MANAGEMENT COMPANY, L.P. Registered adviser, Diversified active $249,896,391 4 held
7 Polar Capital Holdings Plc Registered adviser, Diversified active $228,755,363 5 held
8 Venrock Adviser, LLC Registered adviser, Concentrated $211,712,050 3 held
9 PRIMECAP MANAGEMENT CO/CA/ Registered adviser, Diversified active $195,029,637 2 held
10 FRANKLIN RESOURCES INC Adviser, Diversified active $189,640,797 11 held

Fund Ownership of AKTS by Fund Type

Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026

Index funds and index ETFs hold 4.39% of shares outstanding.

Fund type Of shares outstanding Shares
Index funds 1.19% 661,110
Index ETFs 3.20% 1,781,648
Active ETFs 0.00% 1,554
Active funds 9.24% 5,137,607
Unclassified 0.00% 0
All registered funds 13.63% 7,581,919
How fund types are measured

Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.

Showing 100 of 115
Export CSV
Holder Value (USD) % of 13F Shares Open

Showing the top 100 of 115 holders. Create a free account to see every holder, past quarters, search, filters and CSV export.

Key facts CIK 2035832 CUSIP 01021M104 13F (30d) 10 filings 10 filers Visit website Investor relations